Anna Marie Wagner is the co-founder and CEO of Transfyr, a stealth startup building the world’s first models that capture and operationalize tacit scientific knowledge. These insights are leveraged to drive scientific robustness, interpretability, and transferability, improving the commercial potential of new innovations and allowing for more seamless collaboration and systems integration across the ecosystem.  

Anna Marie's career has spanned investing and operating roles in both hypergrowth and mature companies. Previously, she was on the executive team at Ginkgo Bioworks (NYSE:DNA), where over the years she built the AI team and oversaw all major strategic transactions, including Ginkgo’s public offering in 2021, raising $1.6 billion in what is still the largest-ever go-public raise in biotech.  

Before Ginkgo, Anna Marie spent nearly a decade at Bain Capital Private Equity, where she invested in companies across industries and geographies, ultimately focusing on vertical software and internet / digital media businesses, where her realized investments averaged over a 60% IRR. 

Anna Marie has served as an advisor or board member to a number of organizations across the public, private, and nonprofit sectors, including DARPA, Owkin/Bioptimus, Bold Eagle, Turbine AI, Potato AI, Digital Biology, Verge Genomics, MassChallenge, and the Boston Museum of Science. She is also an Executive Fellow at Harvard Business School, where she co-teaches an elective course on failure (and loves the irony!) and supports the entrepreneurship group.